Kairos Pharma (KAPA) Net Equity Issued and Repurchased (2025)
Kairos Pharma's Net Equity Issued and Repurchased came in at $3.06 million for FY2025, down 44.6% from $5.52 million in FY2024.
Powered by 
Analysis
Kairos Pharma (KAPA) Net Equity Issued and Repurchased (2025) Analysis & Trends
- Per Business Quant, earlier years put Net Equity Issued and Repurchased at $5.52 million in FY2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,165.22 Bn | 1,133.81 Bn | 19.71 Bn | -1.60 Bn |
| 2 | Johnson & Johnson | 646.28 Bn | 566.14 Bn | 17.30 Bn | -966.00 Mn |
| 3 | AbbVie | 503.17 Bn | 476.28 Bn | 12.70 Bn | -9.00 Mn |
| 4 | Merck | 365.23 Bn | 319.60 Bn | 12.21 Bn | -714.00 Mn |
| 5 | Novartis Ag | 302.66 Bn | 266.65 Bn | 11.24 Bn | -1.20 Bn |
| 6 | Astrazeneca | 267.39 Bn | 241.08 Bn | 12.86 Bn | 6.00 Mn |
| 7 | Amgen | 241.61 Bn | 197.01 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | -346.00 Mn |
| 9 | Pfizer | 172.91 Bn | 119.55 Bn | 10.94 Bn | - |
| 10 | Kairos Pharma | 10.01 Mn | -2.40 Mn | - | - |
API Access
Kairos Pharma Net Equity Issued and Repurchased API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=KAPA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-equity-issued-and-repurchased", "ticker": "KAPA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=KAPA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();